期刊
CLINICAL SCIENCE
卷 122, 期 9-10, 页码 439-447出版社
PORTLAND PRESS LTD
DOI: 10.1042/CS20110159
关键词
diagnosis; hypertension; kidney; microRNA (miRNA); therapy; translational research
资金
- National Institutes of Health [HL085267, DK084405, HL077263, HL082798, HL029587]
- National Research Service
- Kern Family Foundation
- American Heart Association
MicroRNA research in humans and mammalian model organisms is in a crucial stage of development. Diagnostic and therapeutic values of microRNAs appear promising, but remain to be established. The physiological and pathophysiological significance of microRNAs is generally recognized, but much better understood in some organ systems and disease areas than others. In the present paper, we review several translational studies of microRNAs, including those showing the potential value of therapeutic agents targeting microRNAs and diagnostic or prognostic microRNA markers detectable in body fluids. We discuss the lessons learned and the experience gained from these studies. Several recent studies have begun to explore translational microRNA research in kidney disease and hypertension. Translational research of microRNAs in the kidney faces unique challenges, but provides many opportunities to develop and apply new methods, and to merge complementary basic and clinical approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据